Entecavir Tablets IP 0.5 Mg – VIRENTA 0.5 Tablets

VIRENTA 0.5 Tablets – Reliable Antiviral Therapy for Long-Term Protection.

VIRENTA 0.5 Tablets – Entecavir Tablets IP 0.5 Mg features Entecavir, a potent guanosine nucleoside analogue and a first-line choice for chronic hepatitis B treatment. It substantially lowers HBV DNA levels and promotes healthier liver tissue, thereby protecting liver function and preventing disease progression. Its high barrier to resistance, sustained antiviral action, and excellent safety profile make it a gold-standard therapy for managing HBV.

Key Benefits of Entecavir Tablets – VIRENTA 0.5 Tablets
✅ High Resistance Barrier – Maintains long-term viral suppression with minimal risk of mutations, making it ideal for extended HBV therapy.
✅ Powerful Antiviral Action – Inhibits all critical steps of HBV polymerase, including priming, reverse transcription, and DNA replication.
✅ Safe and Well-Tolerated – Low incidence of kidney or bone-related side effects, with once-daily dosing for improved patient adherence.

Recommended By Specialists:
👨‍⚕️ Hepatologists: Specifically prescribed for treating chronic hepatitis B and advanced liver disorders.
👨‍⚕️ Gastroenterologists: For managing HBV-associated liver issues, cirrhosis, and related gastrointestinal complications.
👨‍⚕️ General Physicians: For early diagnosis, ongoing monitoring, and referral of patients with chronic HBV.

INDICATIONS:
✅ Chronic Hepatitis B Virus (HBV) Infection
✅ Compensated Liver Disease Associated with HBV
✅ Prevention of HBV Reactivation
✅ Long-Term Viral Suppression in HBV Patients
✅ HBV Prophylaxis in Post-Liver Transplant Cases